Chief Financial Officer
Tolga joined Agomab as CFO in 2021 and brings over 25 years of strategic financial management and corporate structuring experience. He previously held board level roles as Chief Financial Officer and Chief Operating Officer at F-star Therapeutics where he was directly involved in a number of licensing and option-to-buy transactions with companies such as Merck, AbbVie and Denali Therapeutics, as well as preparing the business to become a clinical-stage, NASDAQ-listed biotech company. Prior to this, he was the Director of Corporate Development at FTSE-100 specialty chemicals and API company Johnson Matthey, and previously worked in various valuation and transaction advisory roles at Andersen. Tolga holds an MA in Economics from the University of Cambridge and is a qualified Chartered Accountant.